Nanjing Nuoin develops diagnostic solutions for infectious pathogens and acute infections.
Founded in 2020 in Nanjing, China, Nanjing Nuoin Biological Technology develops solutions for infectious pathogen diagnosis and treatment. Its rapid detection systems use nucleic acid extraction, host removal, PCR primer design, pathogen databases and data analysis tools. The team has experience at Shenzhen Huada Gene Technology, Vazyme Biotech, Guangzhou Burning Rock Medical Examination Institute and Berry Genomics. The company planned to use pre-Series A funding for product registration, development and clinical research services.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in